A literature review to identify factors that determine policies for influenza vaccination |
| |
| Affiliation: | 1. Université Lumière Lyon 2, Lyon F-69007, France;2. CNRS, GATE Lyon Saint-Etienne, Ecully F-69130, France;3. Direction of Clinical Research and Innovation, DRCI, Léon Bérard Cancer Centre, Lyon, France;4. Open Rome; Coordination Nationale des Groupes Régionaux d’Observation de la Grippe, Réseau des GROG, Paris, France;5. Netherlands Institute For Health Services Research (NIVEL), Utrecht, The Netherlands;6. University Claude Bernard, Lyon 1, EAM 4128 Lyon, France;1. Department of Family Medicine, University of Tartu, Puusepa 1a, 50406 Tartu, Estonia;2. Klaster Baltic, Gildi 12, 51007 Tartu, Estonia;3. Estonian Health Insurance Fund, Lembitu 10, 10114 Tallinn, Estonia;1. Servicio de Reumatología, Hospital Universitario de Salamanca, Salamanca, España;2. Instituto de Investigación Biomédica de Salamanca, Salamanca, España (IBSAL);1. Grupo de Física Teórica (GFT), Universidade Estadual do Ceará, UECE-FECLI, Iguatu-CE, Brazil;2. Departamento de Física, Universidade Federal da Paraíba, Caixa Postal 5008, CEP 58051-970, João Pessoa-PB, Brazil;3. Grupo de Física Teórica (GFT), Universidade Estadual do Ceará-UECE, CEP 60740-000, Fortaleza-CE, Brazil;1. Global Solutions for Infectious Diseases, South San Francisco, CA, USA;2. Vaccine Consultant, Beijing, PR China;3. Former WHO Medical Officer, EPI, Democratic People''s Republic of Korea;4. Division of Clinical Trials and Pharmacovigilance, Instituto Butantan, Sao Paulo, Brazil |
| |
| Abstract: | ObjectivesTo conduct a literature review of influenza vaccination policy, describing roles and interactions between stakeholders and the factors influencing policy-making.MethodsMajor databases were searched using keywords related to influenza vaccination, decision-making and healthpolicy. Titles and abstracts were screened according to defined criteria using independent reviewers. Selected articles were analysed and compared against a checklist.Results342 papers were identified, but only 111 included. A wide range of countries was represented in articles published in 1994–2012. We identified numerous stakeholders at the national and international level and found a variety of interactions between them. Using these data, we suggest a scheme for the most important stakeholders and their interactions. Determinants of policy-making were mainly related to the vaccine/disease, political-economic context, and stakeholders communication. The most relevant evidence was clinical/epidemiological studies. After the 2009 pandemic: the importance of mathematical modelling and ethical issues was greater; and the need for better communication between stakeholders was emphasised.ConclusionsThe relevance of evidence and factors influencing policy-making varied between countries, according to complex interactions between the stakeholders involved at different levels of decision-making process. These interactions remain unclear, especially at national level, where the most important influenza policy decisions are made. To better define and understand the exact interactions and use of evidence, we recommend undertaking future qualitative studies at national level using small number of countries. |
| |
| Keywords: | Policy-making Influenza vaccination Health policy Decision-making |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
